Psychedelics African psilocybin cultivator Psyence gets C$600K investment The final C$124,000-dollar tranche was obtained on Jul. 4 Rowan DunneJuly 10, 2025
Psychedelics Psyence BioMed invests half a million into natural psychedelics operator PsyLabs In conjunction with the financing, Psyence has secured the option to receive a steady supply of ibogaine from PsyLabs Rowan DunneApril 16, 2025